- Home
- LIDR vs HOTH Comparison
LIDR vs HOTH Comparison
Compare LIDR & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- HOTH
- Stock Information
- Founded
- LIDR 2013
- HOTH 2017
- Country
- LIDR United States
- HOTH United States
- Employees
- LIDR N/A
- HOTH N/A
- Industry
- LIDR Auto Parts:O.E.M.
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- HOTH Health Care
- Exchange
- LIDR Nasdaq
- HOTH Nasdaq
- Market Cap
- LIDR 9.8M
- HOTH 8.3M
- IPO Year
- LIDR N/A
- HOTH 2019
- Fundamental
- Price
- LIDR $0.77
- HOTH $1.06
- Analyst Decision
- LIDR Hold
- HOTH Strong Buy
- Analyst Count
- LIDR 1
- HOTH 4
- Target Price
- LIDR N/A
- HOTH $4.75
- AVG Volume (30 Days)
- LIDR 961.6K
- HOTH 673.3K
- Earning Date
- LIDR 02-20-2025
- HOTH 03-27-2025
- Dividend Yield
- LIDR N/A
- HOTH N/A
- EPS Growth
- LIDR N/A
- HOTH N/A
- EPS
- LIDR N/A
- HOTH N/A
- Revenue
- LIDR $225,000.00
- HOTH N/A
- Revenue This Year
- LIDR N/A
- HOTH N/A
- Revenue Next Year
- LIDR $2,650.00
- HOTH N/A
- P/E Ratio
- LIDR N/A
- HOTH N/A
- Revenue Growth
- LIDR N/A
- HOTH N/A
- 52 Week Low
- LIDR $0.75
- HOTH $0.58
- 52 Week High
- LIDR $5.15
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- LIDR 39.04
- HOTH 42.86
- Support Level
- LIDR $0.78
- HOTH $1.01
- Resistance Level
- LIDR $0.99
- HOTH $1.09
- Average True Range (ATR)
- LIDR 0.08
- HOTH 0.08
- MACD
- LIDR 0.01
- HOTH -0.02
- Stochastic Oscillator
- LIDR 6.79
- HOTH 25.93
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.